Evidence map›Paper›PMID 29150567›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity.

Alejandro F Alice, Gwen Kramer, Shelly Bambina, Jason R Baird, Keith S Bahjat, Michael J Gough, Marka R Crittenden

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. MicroRNA-30e-5p Regulates SOCS1 and SOCS3 During Bacterial Infection.Frontiers in cellular and infection microbiology · 2020
    Article
  8. Cyclooxygenase-1 and -2 Play Contrasting Roles inJournal of immunology (Baltimore, Md. : 1950) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alejandro F AliceEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; and.
Gwen KramerEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; and.
Shelly BambinaEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; and.
Jason R BairdEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; and.
Keith S BahjatEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; and.
Michael J GoughEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; and.ORCID 0000-0002-5575-0074
Marka R CrittendenEarle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213; and marka.crittenden@providence.org.
Providence Portland Medical Center · US

Funding

High dose radiation therapy to direct immune responses to pancreatic cancerR01CA182311 · NCI · PROVIDENCE PORTLAND MEDICAL CENTER · PI GOUGH, MICHAEL JAMES · 2014 to 2023
$3.6M
Increasing the potency of Listeria monocytogenes-based vaccines by eliminating vaccine-related gamma delta T cell responses.R21AI126151 · NIAID · PROVIDENCE PORTLAND MEDICAL CENTER · PI CRITTENDEN, MARKA · 2016 to 2017
$454k
Tetravalent bispecific fusion antibody for immunotherapyR43CA110297 · NCI · IMMUNOMEDICS, INC. · PI QU, ZHENGXING · 2004 to 2004
$134k
NCI NIH HHS R01 CA182311NCI NIH HHS R43 CA110297NIAID NIH HHS R21 AI126151
6 · The paper itself

Abstract

Although prophylactic vaccines provide protective humoral immunity against infectious agents, vaccines that elicit potent CD8 T cell responses are valuable tools to shape and drive cellular immunity against cancer and intracellular infection. In particular, IFN-γ-polarized cytotoxic CD8 T cell immunity is considered optimal for protective immunity against intracellular Ags. Suppressor of cytokine signaling (SOCS)1 is a cross-functional negative regulator of TLR and cytokine receptor signaling via degradation of the receptor-signaling complex. We hypothesized that loss of SOCS1 in dendritic cells (DCs) would improve T cell responses by accentuating IFN-γ-directed immune responses. We tested this hypothesis using a recombinant

Indexed as

Adaptive ImmunityAnimalsBacterial VaccinesCD11c AntigenCD8-Positive T-LymphocytesCells, CulturedCytotoxicity, ImmunologicDendritic CellsHumansImmunity, InnateInterferon-gammaKiller Cells, NaturalListeria monocytogenesListeriosisMiceMice, Inbred C57BLBacterial VaccinesCD11c AntigenInterferon-gammaSuppressor of Cytokine Signaling 1 Protein

Identifiers

PMID29150567
PMCPMC5736417
OpenAlexW2770745523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.